PAIN
Volume 147, Issue 1 , Pages 9-10, 15 December 2009

Etifoxine (Stresam®) for chemotherapy-induced pain?

Institute of Pharmacology and Toxicology, University of Zurich, and Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. Tel.: +41 44 6355912; fax: +41 44 6355988.

Received 29 August 2009; accepted 18 September 2009. published online 12 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3959(09)00557-0

doi:10.1016/j.pain.2009.09.021

Refers to article:

  • Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3α-reduced neurosteroids , 28 September 2009

    Maya Aouad, Alexandre Charlet, Jean-Luc Rodeau, Pierrick Poisbeau
    PAIN 15 December 2009 (Vol. 147, Issue 1, Pages 54-59)

PAIN
Volume 147, Issue 1 , Pages 9-10, 15 December 2009

Article Tools